5ACC/AHA Task force on practic Cuidelines Committee to Revise the 1995 Cuidelines for Evalvation and Manaagement of Heart Failure [ J]. Jameoll cardio1,2001,38 :2101 - 2112.
6Sudoh T, Kangawa K, Minamino N ,et al. A natriuretic peptide in porcine brain. Nature[ J]. 1988,322:78 - 81.
7Yoshihiko S, Akioo D, Teruyoy H, et al. Application of NT - pro - BNP and BNP measurements in cardiac care : a more disceming marker for the detection and evaluation of heart failure [ J ]. Europ J Heart Failure,2004,62(6) :295.
8Selvais P, Donckier J, Roberta,et al. Cardiac natriuretic peptides for diagnosis and risks tratification in heart failure : influences of left ventriculardys function and coronary artery disease on cardiac hormonal activation [ J]. EurJ Clin Invest, 1998,28:636 - 639.
9DOUST J A,PIETRZAK E,DOBSON A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure system atic review [ J ]. BM J ,2005,330:625 - 634.
10SELVAIS P, DONCKIER J, ROBERT A, et al. Cardiac natriuretic peptides for diagnosis and risks tratification in heart failure: influences of left ventriculardys function and coronary artery disease on cardiac hormonal activation [ J ]. Eur J Clin Invest, 1998,28 : 636 - 639.
